Dr. Seth Lederman
Equibles does not estimate personal net worth.
About Dr. Seth Lederman
Tonix Pharmaceuticals Holding Corp. reported in an 8-K filed August 18, 2026 that Dr. Seth Lederman was appointed Interim Chief Medical Officer, effective August 18, 2026. Tonix Pharmaceuticals Holding Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tonix Pharmaceuticals Holding Corp. includes Seth Lederman (CEO and Board Member), Bradley Saenger (CFO), Siobhan Fogarty (CTO) and 7 others.
“On August 18, 2026, the Board of Directors of Tonix Pharmaceuticals Holding Corp. (the “Company”) appointed Dr. Seth Lederman, the Company’s President and Chief Executive Officer, as the Company’s Interim Chief Medical Officer.”
Affiliation history
-
Current
2026-08-18–present
Company network
Leadership on record at Tonix Pharmaceuticals Holding Corp.
- Seth Lederman CEO, Board Member
- Bradley Saenger CFO
- Siobhan Fogarty CTO
- Adeoye Olukotun Board Member
- Carolyn E. Taylor Board Member
- Carolyn Taylor Board Member
- David Grange Board Member
- James Hunter Board Member
- James Treco Board Member
- Margaret Smith Bell Board Member